
Company Info
Phone(866) 755-4744
Year Established
2017
Contacts
Jack SpringerPresident & CEO
Company Description
Nectero Therapeutics is developing an investigational treatment with the potential to stabilize growth and minimize risk of rupture of small to mid-sized AAA. Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System uses an endovascular approach to deliver a proprietary mixture to the site of the aneurysm.